Overview

* Loblaw ( LBLCF ) Q3 revenue grows 4.6%, meeting analyst expectations

* Adjusted EPS for Q3 beats analyst estimates, reflecting strong operational performance

* Company completes four-for-one stock split, enhancing share liquidity

Outlook

* Loblaw ( LBLCF ) expects full-year adjusted EPS growth to increase to low double-digits

* Company plans C$1.9 bln net capital investments in 2025

* Loblaw ( LBLCF ) to return capital via share repurchases

Result Drivers

* VALUE OFFERINGS - Everyday value offerings and personalized loyalty rewards drove higher customer engagement, boosting sales

* NEW STORE OPENINGS - Opening of 19 new stores, including Maxi and NoFrills, expanded discount options and increased customer traffic

* SPECIALTY DRUG GROWTH - Specialty drug growth in Drug Retail segment contributed to strong results

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Meet C$19.40 C$19.40

Revenue bln bln (8

Analysts

)

Q3 Beat C$0.69 C$0.68

Adjusted (8

EPS Analysts

)

Q3 EPS C$0.66

Q3 Beat C$828 C$815.09

Adjusted mln mln (3

Net Analysts

Income )

Q3 Net C$794

Income mln

Q3 Beat C$2.22 C$2.19

Adjusted bln bln (7

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the food retail & distribution peer group is "buy"

* Wall Street's median 12-month price target for Loblaw Companies Ltd ( LBLCF ) is C$61.13, about 7.5% above its November 11 closing price of C$56.53

* The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 22 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)